Fostering interactions among industry, investors, government, and academia

LabCentral 2018 Impact Report: Resident Companies Raised the Equivalent of 40% of Early Life Sciences VC Funding in Massachusetts and 6% of U.S. Life Sciences IPOs

Kendall Square launchpad for high-potential life sciences and biotech start-ups releases annual report detailing economic development, community building and other impacts

View Full Article »